Streetbeat News

Regulatory

ADVM

Adverum Biotechnologies (NASDAQ:ADVM) announced that the FDA has granted RMAT designation for its gene therapy product candidate, Ixo-vec, for the treatment of wet AMD.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:12 pm

RAIL

FreightCar America, Inc. (NASDAQ:RAIL) has secured a multi-year agreement to upgrade over 1,000 DOT 111 tank cars to DOT 117R tank cars over a two-year period. This expansion into tank car conversions highlights the company's efforts to diversify its offerings and meet federally mandated safety standards.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:05 pm

OPTT

Ocean Power Technologies (NYSE:OPTT) has announced a patent pending for its new docking and recharging buoy technology designed for the Wave Adaptive Modular Vessel (WAM-V) Unmanned Surface Vehicle (USV). This innovation enhances the operational efficiency and range of USVs, making it valuable for oceanographic research, environmental monitoring, and defense applications.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:04 pm

RUN

Sunrun's greenhouse gas emissions reduction targets have been approved by the Science Based Targets Initiative, and the company has set a verified net-zero target by 2050.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 12:01 pm

ABUS

Trading halt status for ABUS was updated at 7:55:00 AM ET. The halt was due to pending news, and trading is expected to resume shortly.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:55 am

GOGO

Gogo Business Aviation is collaborating with Duncan Aviation to pursue a Supplemental Type Certificate (STC) from the FAA for the installation of Gogo 5G on Bombardier Learjet 40/45/70/75 aircraft.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:54 am

PDSB

PDS Biotechnology Corporation (NASDAQ:PDSB) has aligned with the FDA on the next steps for its Phase 3 VERSATILE-003 trial targeting HPV16-positive head and neck cancer. The trial is set to begin in Q4 2024. A conference call will be held today at 8:00 a.m. ET to discuss the details.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:51 am

TNXP

Tonix Pharmaceuticals (NASDAQ:TNXP) has received FDA Fast Track designation for its fibromyalgia treatment, TNX-102 SL. This designation facilitates the development and review process, potentially bringing the drug to market sooner. TNX-102 SL has shown significant improvements in fibromyalgia symptoms in Phase 3 trials and is well tolerated. Tonix plans to submit a New Drug Application (NDA) in the second half of the year and may request Priority Review.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:49 am

IMRX

Immuneering shares are trading higher after the company announced that IMM-1-104 was granted Fast Track designation from the FDA.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:46 am

IDA

IDACORP has raised the lower-end of its FY24 earnings guidance to a range of $5.30-$5.45 per share, citing additional tax credits from Idaho Power's 2023 battery storage projects and regulatory mechanisms.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2024 | 11:38 am